Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Marocaine Ste de Therapeutique SA (SOT)

Casablanca
Currency in MAD
945.00
-4.00(-0.42%)
Closed
SOT Scorecard
Full Analysis
Trading at a high P/E ratio relative to near-term earnings growth
Fair Value
Day's Range
930.00945.00
52 wk Range
881.001,075.00
Key Statistics
Edit
Bid/Ask
927.00 / 955.00
Prev. Close
949
Open
930
Day's Range
930-945
52 wk Range
881-1,075
Volume
11
Average Vol. (3m)
693
1-Year Change
-7.5%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SOT Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry
Show more

Marocaine Ste de Therapeutique SA Company Profile

Société de Therapeutique Marocaine S.A., a pharmaceutical company, engages in the manufacturing and sale of medicines in Morocco. It offers products in various therapeutic areas, including allergology, oncology, cardiology, dental, dermatology, endocrinology, gastroenterology, gynecology, ophthalmology, ENT, pediatric, pulmonology, reanimation, rheumatology, central nervous system (CNS), and urology, as well as antibiotics and other generic drugs. The company also provides its products in various forms, such as tablets, capsules, pouches, syrups, suspensions, powders, collyriums, suppositories, creams and pomades, injectable solutions, and self-injectable syringes. In addition, it imports licensed medicines and dental products, as well as biotechnology products; and manufactures medicines under other labels. The company exports its products to Europe, Maghreb, Sub-Saharan Africa, and the Persian Gulf. Société de Therapeutique Marocaine S.A. was founded in 1976 and is based in Bouskoura, Morocco.

Employees
0
Market
Morocco

Compare SOT to Peers and Sector

Metrics to compare
SOT
Peers
Sector
Relationship
P/E Ratio
24.4x18.7x−0.7x
PEG Ratio
4.400.070.00
Price / Book
4.5x1.9x2.6x
Price / LTM Sales
2.6x1.8x3.2x
Upside (Analyst Target)
-14.9%44.5%
Fair Value Upside
Unlock19.7%6.6%Unlock

Analysts' Recommendations

0 Buy
1 Hold
0 Sell
Ratings:
0 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 0.00

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 38.11
Dividend Yield
1.79%
Industry Median 2.84%
Annualized Payout
17
Paid annually
5-Years Growth
-
Growth Streak

People Also Watch

2,005.00
SMI
-2.20%
53.41
DHO
+0.77%
275.00
LES
-0.36%
713.90
CTM
+9.51%
418.80
SRM
-2.01%

FAQ

What Is the Marocaine Ste de Therapeutique (SOT) Stock Price Today?

The Marocaine Ste de Therapeutique stock price today is 945.00

What Stock Exchange Does Marocaine Ste de Therapeutique Trade On?

Marocaine Ste de Therapeutique is listed and trades on the Casablanca stock exchange.

What Is the Stock Symbol for Marocaine Ste de Therapeutique?

The stock symbol for Marocaine Ste de Therapeutique is "SOT."

Does Marocaine Ste de Therapeutique Pay Dividends? What’s The Current Dividend Yield?

The Marocaine Ste de Therapeutique dividend yield is 1.79%.

What Is the Marocaine Ste de Therapeutique Market Cap?

As of today, Marocaine Ste de Therapeutique market cap is 6.80B.

What is Marocaine Ste de Therapeutique Earnings Per Share?

The Marocaine Ste de Therapeutique EPS is 38.11.

From a Technical Analysis Perspective, Is SOT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.